Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202688

Expand all

PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)
225MG
Marketing Status: Prescription

Active Ingredient: PROPAFENONE HYDROCHLORIDE
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 225MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202688
Product Number: 001
Approval Date: Aug 24, 2015
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)
325MG
Marketing Status: Prescription

Active Ingredient: PROPAFENONE HYDROCHLORIDE
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 325MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202688
Product Number: 002
Approval Date: Aug 24, 2015
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)
425MG
Marketing Status: Prescription

Active Ingredient: PROPAFENONE HYDROCHLORIDE
Proprietary Name: PROPAFENONE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 425MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202688
Product Number: 003
Approval Date: Aug 24, 2015
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information